We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
40 hedge funds and large institutions have $28.2M invested in Larimar Therapeutics in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
4.88% less ownership
Funds ownership: 86.15% → 81.27% (-4.9%)
11% less funds holding
Funds holding: 45 → 40 (-5)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
54% less capital invested
Capital invested by funds: $61.8M → $28.2M (-$33.6M)
71% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 14
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
40
Holders Change
-5
Holders Change %
-11.11%
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
1
Increased
4
Reduced
14
Closed
5
Calls
$22K
Puts
–
Net Calls
+$22K
Net Calls Change
-$260K
Top Buyers
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$174K |
| 2 |
Renaissance Technologies
New York
|
+$8.27K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.3K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$230 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$139 |
